Revised SPC: Sovaldi (sofosbuvir) 400 mg film coated tablets

Sections 4.4 and 4.5 have been updated to strengthen warnings on bradyarrhythmia involving drug-drug interaction between sofosbuvir-containing products and amiodarone following PRAC recommendation for Epclusa (sofosbuvir and velpatasvir) adopted on 16 January 2020.

Source:

electronic Medicines compendium